|Bid||0.00 x 800|
|Ask||0.00 x 1200|
|Day's Range||12.94 - 14.40|
|52 Week Range||12.93 - 25.70|
|Beta (5Y Monthly)||1.17|
|PE Ratio (TTM)||27.05|
|Earnings Date||Jun 24, 2020 - Jun 28, 2020|
|Forward Dividend & Yield||1.04 (7.24%)|
|Ex-Dividend Date||Apr 07, 2020|
|1y Target Est||23.42|
Patterson Cos. (PDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Unfortunately for some shareholders, the Patterson Companies (NASDAQ:PDCO) share price has dived 34% in the last...
The Board of Directors of Patterson Companies, Inc. (Nasdaq: PDCO) today declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on, or about, April 24, 2020, to shareholders of record as of the close of business on April 10, 2020.
Patterson Companies (PDCO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Patterson Companies (PDCO) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll show how you can use...
Patterson Cos. (PDCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Patterson Companies' (PDCO) fiscal third-quarter results benefit from higher revenues and solid show by Dental as well as Animal Health segments.
Patterson Cos. (PDCO) delivered earnings and revenue surprises of 27.03% and 2.75%, respectively, for the quarter ended January 2020. Do the numbers hold clues to what lies ahead for the stock?
Patterson Cos. shares rose 10% in premarket trade Thursday, after the medical supplies company beat earnings estimates for its fiscal third quarter. The company said it had net income of $23.2 million. or 24 cents a share, in the quarter to Jan. 25, down from $31.2 million, or 33 cents a share, in the year-earlier period. Adjusted per-share earnings came to 47 cents, ahead of the 36 cents FactSet consensus. Sales rose 4.3% to $1.46 billion, also ahead of the $1.42 billion FactSet consensus. Sales at the company's dental division, which represents about 44% of total sales, came to $626.6 million, up from $479.7 million a year ago. Animal health sales, which totaled 56% of total sales, came to $817.3 million, up from $807.5 million a year ago. The company raised its full-year guidance and now expects EPS of 49 cents to 54 cents and adjusted EPS of $1.50 to $1.55. The FactSet consensus is for full-year EPS of $1.41. Shares have gained 1.4% in the last 12 months through Wednesday, while the S&P 500 has gained 12%.
The drop, caused by the spread of the Covid-19 Coronavirus to new countries like Italy and Iran, ate up all of the Dow Jones Industrial Average’s gains in 2020.
Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2020 third-quarter conference call on Thursday, February 27, 2020 at 9 a.m. CT (10 a.m. ET). The company’s earnings release will be issued that morning before the market opens.
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Patterson Companies, Inc. (PDCO) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Dentsply (XRAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.